Navigation Links
Symmetry Medical to Present at UBS Global Life Sciences Conference
Date:9/10/2009

WARSAW, Ind., Sept. 10 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief Executive Officer, and Fred L. Hite, Senior Vice President and Chief Financial Officer, are scheduled to present at the UBS Global Life Sciences Conference at the Grand Hyatt Grand Central Hotel in New York City on Monday, September 21, 2009 at 4:30 p.m. ET.

A live Web cast of the presentation will be available on Symmetry Medical's Web site at www.symmetrymedical.com. Presentation slides will be posted on the Web site before the presentation begins. A replay of the Web cast will be available for 60 days after the date of the presentation.

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading independent provider of implants and related instruments and cases to the orthopedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including arthroscopy, dental, laparoscopy, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as the aerospace market.

    Investors/Media:                      Contact:
    The Ruth Group                        Symmetry Medical Inc.
    Nick Laudico/Jason Rando              Fred L. Hite
    (646) 536-7030/7025                   Senior Vice President
    nlaudico@theruthgroup.com             Chief Financial Officer
    jrando@theruthgroup.com               (574) 371-2218


'/>"/>
SOURCE Symmetry Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Symmetry Medical to Present at Thomas Weisel Partners 2009 Healthcare Conference
2. Symmetry Medical Reports Second Quarter 2009 Financial Results
3. Symmetry Medical to Report Second Quarter 2009 Financial Results on August 6, 2009
4. Symmetry Medical Appoints Chairman and Two Directors
5. Symmetry Medical Reports First Quarter 2009 Financial Results
6. Symmetry Medical to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
7. Symmetry Medical to Report First Quarter 2009 Financial Results on May 7, 2009
8. Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results
9. Symmetry Medical to Present at Canaccord Adams Musculoskeletal Conference
10. Symmetry Medical to Report Fourth Quarter and Full Year 2008 Financial Results on February 24, 2009
11. Symmetry Medical to Present at 20th Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: